Skip to content

Public FDA record

Z-1498-04: Architect Anti-HBs Reagent Kit; list 7C18-20, 4 x 100 tests, list 7C18-25, 100 tests and list 7C18-30, 4

Recall record Z-1498-04 for Abbott Laboratories HPD/ADD/GPRD. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1498-04
Company in FDA record
Abbott Laboratories HPD/ADD/GPRD
FDA classification date
Sep 30, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

There is a potential for significant differences in quantitative results for certain specimens when using the affected reagent lots.

Source facts

Action
Abbott affiliates in Canada, Germany, Australia, New Zealand, England and Japan were e-mailed copies of the recall letter on 8/27/04 for translation where needed and dissemination to their accounts receiving the suspect lots. The end users were advised of the potential for significant differences in quantitative results for certain specimens and were instructed to discontinue use and destroy any of the affected lots remaining.
Initiated
2004-08-27
Root cause
Other
Terminated
2005-07-29
Distribution
Canada, Japan, Australia, New Zealand, Germany and England
Recall number
Z-1498-04
Recall status
Terminated
CDRH record ID
34786
FDA classified
2004-09-30
Recall event number
29922

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗